Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in Behçet's disease and correlation with disease activity.

@article{Kurtipek2016PlasmasolubleUP,
  title={Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in Behçet's disease and correlation with disease activity.},
  author={Gulcan Saylam Kurtipek and Recep Keşli and Fatma Tuncez Akyurek and Fikret Akyurek and Arzu Ataseven and Yuksel Terzi},
  journal={International journal of rheumatic diseases},
  year={2016},
  volume={21 4},
  pages={
          866-870
        }
}
BACKGROUND Soluble urokinase plasminogen activator receptor (suPAR), a new biomarker, is a soluble form of membrane-bound receptors secreted from different immune cells. The aim of the present study is to determine plasma suPAR levels in Behçet's disease and their correlation with disease activity. METHODS Thirty Behçet's disease patients determined according to the International Study Group criteria for Behçet's disease diagnosis and 41 healthy subjects were included in the present study… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 32 REFERENCES

Diagnostic accuracy of soluble urokinase plasminogen activator receptor ( suPAR ) for prediction of bacteremia in patients with systemic inflammatory response syndrome

RB Raggam, J Wagner, T Valentin
  • Hoenigl Clin Biochem
  • 2013

Pathophysiology of the Behcet ’ s disease

B Adam, E Calikoglu
  • Patholog Res Int
  • 2012

Similar Papers

Loading similar papers…